References
- Gene Therapy . American Medical Association. www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/current-topics/gene-therapy.page?.
- Peer D . Harnessing RNAi nanomedicine for precision therapy. Mol. Cell. Ther. doi:10.1186/2052-8426-2-5 eCollection (2014).
- Wittrup A Lieberman J . Knocking down disease: a progress report on siRNA therapeutics. Nat. Rev. Genet.16 (9), 543–552 (2015).
- Daka A Peer D . RNAi-based nanomedicines for targeted personalized therapy. Adv. Drug Deliv. Rev.64 (13), 1508–1521 (2012).
- Peer D Karp JM Hong S Farokhzad OC Margalit R Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol.2 (12), 751–760 (2007).
- Junquera E Aicart E . Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors. Adv. Colloid Interface Sci. doi:10.1016/j.cis.2015.07.003 (2015) ( Epub ahead of print).
- Ozcan G Ozpolat B Coleman RL Sood AK Lopez-Berestein G . Preclinical and clinical development of siRNA-based therapeutics. Adv. Drug Deliv. Rev.87, 108–119 (2015).
- Lachelt U Wagner E . Nucleic acid therapeutics using polyplexes: a journey of 50 years (and beyond). Chem. Rev.115 (19), 11043–11078 (2015).
- Peer D Park EJ Morishita Y Carman CV Shimaoka M . Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science319 (5863), 627–630 (2008).
- Cohen K Emmanuel R Kisin-Finfer E Shabat D Peer D . Modulation of drug resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted nanoparticle clusters. ACS Nano8 (3), 2183–2195 (2014).
- Cohen ZR Ramishetti S Peshes-Yaloz N et al. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles. ACS Nano9 (2), 1581–1591 (2015).
- Ramishetti S Kedmi R Goldsmith M et al. Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles. ACS Nano9 (7), 6706–6716 (2015).
- Rosenblum D Peer D . Omics-based nanomedicine: the future of personalized oncology. Cancer Lett.352 (1), 126–136 (2014).
- Walsh C Ou K Belliveau NM et al. Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications. Methods Mol. Biol.1141, 109–120 (2014).